Vaccination in Europe: "There is only France left to support the Commission today"
Audio 06:24
Laszlo Cservak, a 75-year-old retiree, receives his first dose of the vaccine developed by Chinese company Sinopharm.
ATTILA KISBENEDEK AFP
By: Florent Guignard
8 mins
With the shortage of vaccines, European countries are acting in dispersed order.
Thus, the countries of the East are turning to the Russian vaccine (not yet approved by the European Medicines Agency), Austria is considering a partnership with Israel, and Switzerland still does not approve the AstraZeneca, while 'it has just been authorized for people over 65 with comorbidities in France.
Could a European strategy be put in place?
Answer with Patrice Martin-Genier, teacher at Sciences Po and Inalco, specialist in European issues.
Publicity
Patrice Martin-Genier is the author of
L'Europe a-elle un futur?
(
Studyrama-Bréal
)
Newsletter
Receive all international news directly in your mailbox
I subscribe
Follow all the international news by downloading the RFI application
google-play-badge_FR
European Union
Coronavirus
On the same subject
Johnson & Johnson vaccine cleared in US, Europe speaks out soon
Covid: collaborations between competing laboratories in the vaccine race are on the rise
Italy blocks exports of AstraZeneca vaccine doses to Australia